Authors' reply to: "Empiric" inositol supplementation in normal-weight non-insulin resistant women with polycystic ovarian disease: from the absence of benefit to the potential adverse effects

Affiliations

¹ Department of Pediatric, Gynecological, Microbiological and Biomedical Sciences, University of Messina, Via C. Valeria 1, 98125, Messina, Italy, antlagana@unime.it.

Comment

Antonio Simone Laganà et al. Arch Gynecol Obstet. 2015 May.

. 2015 May;291(5):959-60.

doi: 10.1007/s00404-015-3663-8.

¹ Department of Pediatric, Gynecological, Microbiological and Biomedical Sciences, University of Messina, Via C. Valeria 1, 98125, Messina, Italy, antlagana@unime.it.

No abstract available

Comment on

Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with D-Chiro-Inositol.
Laganà AS, Barbaro L, Pizzo A. Laganà AS, et al. Arch Gynecol Obstet. 2015 May;291(5):1181-6. doi: 10.1007/s00404-014-3552-6. Epub 2014 Nov 22. Arch Gynecol Obstet. 2015. PMID: 25416201
"Empiric" inositol supplementation in normal-weight non insulin resistant women with polycystic ovarian disease: from the absence of benefit to the potential adverse effects.
Vitagliano A, Quaranta M, Noventa M, Gizzo S. Vitagliano A, et al. Arch Gynecol Obstet. 2015 May;291(5):955-7. doi: 10.1007/s00404-015-3662-9. Epub 2015 Feb 17. Arch Gynecol Obstet. 2015. PMID: 25687659 No abstract available.